Ellie Smith

Ellie Smith has extensive experience in the pharmaceutical and clinical research industry. Ellie is currently working as the Vice President of Clinical Operations at EyePoint Pharmaceuticals since January 2022. Prior to this, they held the position of Director of Clinical Operations at EyePoint Pharmaceuticals from November 2020 to January 2022.

Before joining EyePoint Pharmaceuticals, Ellie worked at Gemini Therapeutics as the Director of Clinical Operations from March 2020 to November 2020. Ellie also gained experience at Alexion Pharmaceuticals, Inc., where they served as the Associate Director of Clinical Project Lead from December 2018 to March 2020.

In 2017, Ellie worked at two different companies. At Beacon Clinical Consulting, LLC, they served as the President and provided clinical development and operations consulting services. Ellie was responsible for program budgeting, study planning, and managing third-party vendors for global clinical trials. Additionally, they conducted protocol development advisory panels with key opinion leaders. Ellie also worked at Notal Vision as the Director of Clinical Outcomes & Health Economics, Medical Affairs. In this role, they developed and implemented clinical outcomes strategy, selected third-party service providers, and managed process improvement projects within the Medical Affairs department.

Ellie's earlier work experience includes roles at Clearside Biomedical, where they worked as the Director of Clinical Trial Management from June 2015 to June 2017. Ellie was responsible for managing clinical operations for ophthalmology clinical trials. Prior to that, they worked at Alcon, A Novartis Division, as the Global Clinical Feasibility and Site Development representative from April 2010 to May 2015. Their responsibilities included building relationships with opinion leaders, planning global clinical trials, recruiting and training research site personnel, and managing study commitments.

Before joining Alcon, Ellie worked at Alcon Laboratories, Inc. as the Global Clinical Team Manager from May 2008 to April 2010. In this role, they trained team members, managed international submissions, facilitated study start-up activities, and provided on-site support. Prior to that, they worked at Kendle International as the Lead Clinical Research Associate from April 2006 to April 2008. Their responsibilities included study management, training team members, and conducting monitoring and site management activities.

Ellie also gained experience at Charles River Laboratories (acquired by Kendle International) as the Global Project Manager from September 2005 to March 2006. In this role, they managed retinal vein occlusion rescue studies, conducted clinical monitoring duties, and planned project schedules and timelines.

Overall, Ellie Smith has held various leadership and management roles in clinical operations, clinical outcomes, and medical affairs throughout their career. Ellie has demonstrated expertise in protocol development, vendor management, and study planning.

Ellie Smith obtained a Master of Science in Clinical Research from The George Washington University School of Medicine and Health Sciences, which they completed from 2004 to 2006. Prior to that, they earned a Bachelor of Science in Biology at Presbyterian College.